+Vote!
VitaBeat (Free subscription) | 27/08/2008
Eli Lilly and Co.'s Cymbalta depression treatment significantly reduced back pain in comparison with a placebo, new studies suggest. The drug is prescribed to treat depression, generalized anxiety disorder, diabetic nerve pain, and fibromyalgia. The pharmaceutical company carried out a study on 236 adults with chronic low back pain who weren't depressed. They took Cymbalta or a placebo drug daily for...
+Vote!
The Trouble With Spikol (Free subscription) | 27/08/2008
So first they come out with a drug that causes diabetes, then covered it up, and they're in a hell of a lot of trouble because of it. And now, guess what? A drug that Lily makes to treat diabetes...
+Vote!
Business Week (Free subscription) | 27/08/2008
Movers: Amylin, Eli Lilly, Dollar Tree, J.Crew, Borders, TalbotsStocks in the news Wednesday Amylin Pharmaceuticals () and Eli Lilly's () diabetes drug Byetta reportedly was linked to four more deaths in patients with pancreatitis, adding to two deaths announced by federal regulators last week. Baird reportedly downgrades to neutral from outperform. Cowen maintains neutral. Dollar Tree () posts $0.42,...
+Vote!
24/7 Wall St. (Free subscription) | 27/08/2008
The National Funeral Directors Association must be sending “thank you” cards to Eli Lilly (LLY) and it partner Amylin (AMLN). Together, the companies developed... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
+Vote!
Inbox Robot: Swiss Reinsurance News (Free subscription) | 27/08/2008
WASHINGTON (AP) _ Eli Lilly and Amylin Pharmaceuticals Inc. on Tuesday reported four new deaths in patients taking Byetta, even as the companies tried to ...
+Vote!
PR News Wire (Free subscription) | 26/08/2008
SAN DIEGO and INDIANAPOLIS, Aug. 26 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (Nasdaq: ) and Eli Lilly and Company (NYSE: )
in a conference call today provided context and additional information
regarding the August 18, 2008 U.S. Food and Drug Administration (FDA)
update to a prior alert for BYETTA(R) (exenatide) injection referencing
pancreatitis. The companies were aware of the pancreatitis...
+Vote!
The Earth Times Online Newspaper (Free subscription) | 26/08/2008
DUBLIN, Ireland - (Business Wire) Research and Markets () has announced the addition of the "The Top 10 World's Leading Pharmaceutical Companies: Eli Lilly" report to their offering. In a highly dynamic and fragmented pharmaceutical market, besieged by intense competition, rapid pace of technological innovations and the uncertainty regarding future government regulations, the ability to anticipate...
+Vote!
Business Wire (Free subscription) | 26/08/2008
The study provides an approximately 50-page worldwide strategic overview of the pharmaceutical market, including sales forecast for major product segments (ethical, OTC, generics); key geographic regions (North America, Western Europe, Japan, Eastern Europe, and Latin America); major drug categories, including cardiovascular, gastrointestinal, antibiotics, CNS, respiratory, musculoskeletal, hormonal/genitourinary,...
+Vote!
VitaBeat (Free subscription) | yesterday
The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more people who'd been taking the medication bringing the total to six. Last week, Eli Lilly & Co. and Amylin Pharmaceuticals Inc.'s diabetes drug Byetta was linked to two deaths and four hospitalizations. All the patients are reported to have died after developing acute pancreatitis, the manufacturer said. The condition...
+Vote!
Forbes (Free subscription) | yesterday
Amylin and Eli Lilly will have to calm investors' fears over its risky diabetes drug.
+Vote!
MarketBeat (Free subscription) | 27/08/2008
Shares of Amlyin Pharmaceuticals have been hit hard Wednesday, falling 26% after the company, along with its partner Eli Lilly, announced that four patients who took the company’s diabetes drug, Byetta, had died of pancreatitis. This follows a similar report of two deaths from the FDA last week. Several analysts have [...]
+Vote!
Medical,Health News and Articles (Free subscription) | 27/08/2008
August 26 — The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more people who’d been taking the medication. The announcement by Eli Lilly and Amylin Pharmaceuticals Inc. came a week after the U.S. Food and Drug Administration said that two Byetta users had died of acute pancreatitis, a [...]
+Vote!
Forbes (Free subscription) | 27/08/2008
Four new deaths stemmed from Amylin and Eli Lilly's diabetes drug, which sent investors running.
+Vote!
Forbes (Free subscription) | 27/08/2008
Amylin Pharmaceuticals and Eli Lilly announce four new deaths among patients taking the diabetes drug.
